ꢀ
F. Leon et al. / Dyes and Pigments 131 (2016) 307e319
317
4.3.2. 2-(4-Aminophenylamino)-4,6-bis(1-naphthylamino)-1,3,5-
triazine (5b)
Following the general procedure using compound 3b (98%). m.p.
103e106 ꢁC (decomp.). 1H NMR (DMSO-d6, 500 MHz)
4.4.2. 1,5-{N,N'-bis-4-[4,6-bis(1-naphthylamino)-1,3,5-triazin-2-yl]
aminophenyl}-3-chloro-1,5-diaza-1,3-pentanodienium
hexafluorophosphate (7b)
d
¼ 4.60 (s,
Following the general procedure using compound 5b, (48%).
2 H), 6.25 (d, J ¼ 8.8 Hz, 2H), 7.09 (d, J ¼ 8.8 Hz), 7.43 (t, J ¼ 8.1 Hz),
7.50 (ABCD system, J ¼ 8.0, 8.0, 1.6 Hz), 7.60 (d, J ¼ 7.3 Hz, 2H), 7.72
(d, J ¼ 8.2, 2H), 7.91 (ABCD system, J ¼ 8.0, 1.6 Hz, 2H), 8.02 (ABCD
system, J ¼ 8.0, 1.6 Hz, 2H), 8.55 (bs, 1H), 8.97 (bs, 2H). 13C NMR
m.p. 148e151 ꢁC (decomp.) (orange powder). 1H NMR (DMSO-d6,
500 MHz)
d
¼ 6.88 (bs, 4H), 7.20 (bs, 2H), 7.45 (m, 8H), 7.52 (ABCD
system, J ¼ 8.0, 8.0, 1.6 Hz, 8 H), 7.60 (d, J ¼ 7.2 Hz, 4H), 7.75 (d,
J ¼ 8.1 Hz, 4H), 7.95 (ABCD system, J ¼ 8.0, 1.6 Hz, 4H), 8.05 (ABCD
system, J ¼ 8.0, 1.6 Hz, 4H), 8.99 (bs, 2H), 9.13 (bs, 4H). 13C NMR
(DMSO-d6, 125 MHz)
d
¼ 113.0, 121.1, 123, 124.4, 125.1, 125.1, 125.3,
127.4, 128.7, 128.9, 133.3, 134.5, 143, 163.6, 165.5. IR: nmax ¼ 3395,
3046, 2980, 1738, 1587, 1479, 806, 791, 770 cmꢀ1. UV: lmax (CH2Cl2)
294 nm (ε dm3 105 mol cmꢀ1 110000). MS: (MALDI-TOF, DHB)
calculated m/z, 469.2015, found, 470.081 [M þ H]þ. Found: C, 74.47;
H, 4.75; N, 21.12. C29H23N7 requires C, 74.18; H, 4.94; N, 20.88%.
(DMSO-d6, 125 MHz)
d
¼ 98, 120.3, 123.5, 123.7, 125.1, 125.5, 125.6,
125.8, 127.9, 129.5, 133.8, 134.8, 164.1, 166. IR: nmax ¼ 3647, 2988,
1748, 1607, 839, 770 cmꢀ1. UV: lmax (CH2Cl2) 304, 373 nm
(ε/dm3 mol. cmꢀ1 60000, 50000). MS: (MALDI-TOF, DHB) calculated
m/z, 1009.3718, found, 1009.419 [M þ H]þ. Found: C, 63.50; H, 4.10;
N, 16.85. C61H46ClF6N14P requires C, 63.40; H, 4.01; N, 16.97%.
4.3.3. 2-(4-Aminophenylamino)-4,6-bis(diphenylamino)-1,3,5-
triazine (5c)
4.4.3. 1,5-{N,N'-bis-4-[4,6-bis(diphenylamino)-1,3,5-triazin-2-yl]
aminophenyl}-3-chloro-1,5-diaza-1,3-pentanodienium
hexafluorophosphate (7c)
Following the general procedure using compound 3c (99%). m.p.
162e164 ꢁC (decomp.). 1H NMR (DMSO-d6, 500 MHz)
d
¼ 4.59 (s,
Following the general procedure using compound 5c, (44%).
m.p. 245e248 ꢁC (decomp.) (orange powder). 1H NMR (DMSO-d6,
2 H), 6.17 (d, J ¼ 8.8 Hz, 2H), 7.00 (d, J ¼ 8.8 Hz, 2H), 7.14 (m, 2H),
7.22 (m, 4H), 7.29 (m, 4H), 8.72 (s, H). 13C NMR (DMSO-d6, 125 MHz)
500 MHz, 80 ꢁC)
d
¼ 6.81 (bs, 2H), 6.85 (d, J ¼ 9.1 Hz, 4H), 7.18 (d,
J ¼ 7.0 Hz, 8H), 7.2e7.4 (m, 32H), 7.31 (m, 4H), 8.17 (bs, 2H), 9.1 (bs,
2H). 13C NMR (DMSO-d6, 125 MHz, 80 ꢁC)
d
¼ 113.2, 120.3, 124.6, 127.2, 127.9, 129.1, 142.7, 143.4, 163, 165.3. IR:
nmax ¼ 3373, 3024, 2968, 1737, 802, 754, 689 cmꢀ1. UV: lmax
(CH2Cl2) 283 nm (ε/dm3 mol. cmꢀ1120000). MS: (MALDI-TOF, DHB)
calculated m/z, 521.6280, found, 522.372 [M þ H]þ. Found: C, 76.28;
H, 4.98; N, 18.62. C33H27N7 requires C, 75.99; H, 5.22; N, 18.80%.
d
¼ 98.1, 116.6, 119.9,
125.5, 127.8, 128.6, 129.1, 143.3, 157, 161.6, 163.3. nmax ¼ 3669, 3647,
3379, 1734, 1647, 1400, 837, 746, 696 cmꢀ1. UV: lmax (CH2Cl2) 279,
381 nm (ε/dm3 mol. cmꢀ1 30000, 20000). MS: (MALDI-TOF, DHB)
calculated m/z, 1113.4344, found, 1113.458 [M þ H]þ. Found: C,
65.70; H, 4.39; N, 15.65. C69H54ClF6N14P requires C, 65.79; H, 4.32;
N, 15.57%.
4.3.4. 2-(4-Aminophenylamino)-4,6-bis(morpholino)-1,3,5-triazine
(5d)
Following the general procedure using compound 3d. Micro-
4.4.4. 1,5-{N,N'-bis-4-[4,6-bis(N,N'-morpholino)-1,3,5-triazin-2-
yl]-aminophenyl}-3-chloro-1,5-diaza-1,3-pentanodienium
hexafluorophosphate (7d)
wave irradiation (130 ꢁC, 90 W) for 90 min (94%). m.p. 208e210 ꢁC
(decomp.). 1H NMR (DMSO-d6, 500 MHz)
d
¼ 3.58 (m, 8H), 3.63 (m,
8H), 4.70 (s, 2H), 6.50 (d, J ¼ 8 Hz, 2H), 7.2 (d, J ¼ 8 Hz, 2H), 8.59 (s,
1H). 13C NMR (DMSO-d6, 125 MHz)
Following the general procedure using compound 5d, (29%).
m.p. 234e237 ꢁC (decomp.) (yellow powder). 1H NMR (DMSO-d6,
d
¼ 43.7, 66.5,114.2, 122.3,129.7,
500 MHz, 80 ꢁC)
d
¼ 3.62 (m, 16H), 3.71 (m, 16H), 7.13 (d, J ¼ 8.8 Hz,
144.1, 164.4, 165.2. IR: nmax ¼ 3744, 2968, 1738, 1364, 1217,
802 cmꢀ1. UV: lmax (CH2Cl2) 275 nm (ε/dm3 mol. cmꢀ1 50000). MS:
(MALDI-TOF, DHB) calculated m/z, 357.1913, found, 358.005
[M þ H]þ. Found: C, 56.90; H, 6.61; N, 27.30. C17H23N7O2 requires C,
57.13; H, 6.49; N, 27.43%.
2H), 7.60 (d, J ¼ 8.8 Hz, 2H), 8.09 (bs, 2H), 8.70 (bs, 2H). 13C NMR
(DMSO-d6, 125 MHz, 80 ꢁC)
d
¼ 42.9, 66.5, 106.1, 115.5, 120.2, 163.6,
164.5. IR: nmax ¼ 3647, 2980, 1748, 1734, 1558, 1217, 1030, 825 cmꢀ1
.
UV: lmax (CH2Cl2) 377 nm (ε/dm3 mol. cmꢀ1 40000). MS: (MALDI-
TOF, DHB) calculated m/z, 785.3515, found, 785.185 [M þ H]þ.
Found: C, 47.78; H, 4.91; N, 21.15. C37H46ClF6N14O4P requires C,
47.72; H, 4.98; N, 21.06%.
4.4. Synthesis of streptocyanines (7). General procedure [47]
In a round-bottomed flask fitted with a reflux condenser, a
mixture of compounds 5 (0.378 mmol) and 6 (0.058 g, 0.189 mmol)
in dry ethanol (25 mL) was heated under reflux for 4 h. The solvent
was removed in vacuum to give the pure product after recrystalli-
zation from 2-propanol.
Acknowledgements
Financial support from the Spanish Ministerio de Ciencia e
ꢀ
Innovacion CTQ2011-22410, CTQ2014-54987-P and PEII-2014-
002A is gratefully acknowledged. F.L. acknowledges a predoctoral
ꢀ
grant from the Programa de Apoyos para la Superacion del Personal
ꢀ
Academico (PASPA) of the UNAM. We acknowledge M.A. Herrero
4.4.1. 1,5-{N,N'-bis-4-[(4,6-bis(4'-methoxyphenylamino)-1,3,5-
triazin-2-yl)-aminophenyl]}-3-chloro-1,5-diaza-1,3-
pentanodienium hexafluorophosphate (7a)
for recording the MALDI-TOF spectra and technical support from
the High Performance Computing Service of the Universidad de
Castilla-La Mancha.
Following the general procedure using compound 5a, (20%).
m.p. 185e187 ꢁC (decomp.) (orange powder). 1H NMR (DMSO-d6,
Appendix A. Supplementary data
500 MHz)
7.64 (bs, 8H), 7.83 (bs, 8H), 8.24 (bs, 2H), 8.99 (bs, 4H), 9.09 (bs, 2H).
13C NMR (DMSO-d6, 125 MHz)
d
¼ 3.75 (s, 12H), 6.88 (d, J ¼ 8.8 Hz, 8H), 7.26 (bs, 4H),
Supplementary data related to this article can be found at http://
d
¼ 55.2, 94.3, 113.5, 120.8, 122.1, 132,
140.2, 154.6, 163.9, 164. IR: nmax ¼ 3647, 2986, 1748, 1734, 1624,
1254, 1105, 837 cmꢀ1. UV: lmax (CH2Cl2) 278, 375 nm (ε/dm3 mol.
cmꢀ1 90000, 50000). MS: (MALDI-TOF, DHB) calculated m/z,
929.3515, found, 929.367 [M þ H]þ. Found: C, 54.68; H, 4.39; N,
18.30. C49H46ClF6N14O4P requires C, 54.73; H, 4.31; N, 18.23%.
References
[1] Meier H. Conjugated oligomers with terminal donoreacceptor substitution.